Form 4: Atai Life Sciences Director, Laurent Fischer, Acquires Stock Options
SEC Form 4
Laurent Fischer, a director at ATAI Life Sciences N.V., acquired stock options for 206,000 common shares on June 13, 2024.
Summary
- On June 13, 2024, Laurent Fischer, a director of ATAI Life Sciences N.V., acquired stock options for 206,000 common shares.
- The exercise price of these options is $1.34.
- The options vest in installments, starting with 1/3 on June 13, 2025, and the remainder in 24 equal monthly installments, fully vesting by June 13, 2027.
- The options expire on June 13, 2034.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock option grants to a director, which doesn't inherently indicate positive or negative sentiment.
Positives
- The acquisition of stock options by a director may indicate confidence in the company's future performance.
Industry Context
This filing is a routine disclosure related to insider transactions and is common for publicly traded companies. It provides transparency into the holdings and transactions of company insiders.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment if viewed as a sign of confidence by a company insider.
Key Dates
| Date | Description |
|---|---|
| 06/13/2024 | Date of transaction: Laurent Fischer acquired stock options for 206,000 common shares. |
| 06/13/2025 | Vesting start date: 1/3rd of the stock options begin to vest. |
| 06/13/2027 | Full vesting date: The stock options are fully vested. |
| 06/13/2034 | Expiration date: The stock options expire. |
| 06/14/2024 | Date of signature by Attorney-in-fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.